SCHEMBL8086591

SCHEMBL8086591

C=C(Nc1cccc(Cl)c1)c1ccc(N2CCOCC2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.56
DGAT1 O75907 1/20 0.54
MAPT P10636 3/20 0.54
LMNA P02545 2/20 0.54
HTT P42858 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 2/20 0.48
KCNQ3 O43525 1/20 0.48
KCNQ2 O43526 1/20 0.48
HPGD P15428 1/20 0.48
PIK3CD O00329 1/20 0.48
CYP3A4 P08684 1/20 0.48
AKT1 P31749 1/20 0.48
PIK3CA P42336 1/20 0.48
PIK3CB P42338 1/20 0.48
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081787 0.90 CNR1 (0.48) CNR2DGAT1MAPTLMNAHTT
SCHEMBL4247530 0.87 MAPT (0.69) CNR2DGAT1MAPTLMNAHTT
SCHEMBL8080886 0.81 AKT1 (0.52) DGAT1MAPTLMNAHTTSMN1; SMN2
SCHEMBL8086323 0.76 KDM4E (0.54) LMNASMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4252309 0.76 P4HTM (0.61) DGAT1MAPTLMNAHTTSMN1; SMN2
SCHEMBL4250152 0.76 MAPT (0.73) DGAT1MAPTLMNAHTTSMN1; SMN2
SCHEMBL4249417 0.76 P4HTM (0.61) DGAT1MAPTLMNAHTTSMN1; SMN2
SCHEMBL13930597 0.75 P4HTM (0.60) CNR2MAPTLMNAHTTSMN1; SMN2
SCHEMBL8080882 0.74 ABL1 (0.53) MAPTLMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL3679282 0.73 P4HTM (0.58) DGAT1MAPTLMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed